Clinical Trials Browser

Phase 1 × Unknown × fludarabine phosphate × Clear all

Hematologic Diseases

NCT01946373 2022-10-04

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

Phase 1 Unknown

20 enrolled

Dermatologic

Melanoma

NCT01619761 2020-02-11

NK Cells in Cord Blood Transplantation

Phase 1 Unknown

13 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02366546 2018-10-24

Investigator Initiated Phase 1 Study of TBI-1301

Phase 1 Unknown

9 enrolled

DermatologicGastrointestinalGynecologicHead & NeckSarcoma

Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Synovial

NCT00006100 2013-12-18

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

Phase 1 Unknown

Lymphoid

Hodgkin Disease, Lymphoma

Clinical Trials

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

NK Cells in Cord Blood Transplantation

Investigator Initiated Phase 1 Study of TBI-1301

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma